Showing results (1-10 of 264) with videos related to

Sort By:
Pageof 27
The Journal of Steroid Biochemistry and Molecular Biology|July 16, 2005
Aromatase inhibitors: future directionsC Kent Osborne, Rachel Schiff
Annual Review of Medicine|October 5, 2010
Mechanisms of endocrine resistance in breast cancerC Kent Osborne, Rachel Schiff
Breast (Edinburgh, Scotland)|September 10, 2013
Biology and therapeutic potential of PI3K signaling in ER+/HER2-negative breast cancerXiaoyong Fu, C Kent Osborne, Rachel Schiff
Transactions of the American Clinical and Climatological Association|July 18, 2020
DE-ESCALATING TREATMENT FOR HER2-POSITIVE EARLY BREAST CANCERC Kent Osborne, Rachel Schiff, Mothamar Rimawi
Annual Review of Medicine|January 15, 2015
Targeting HER2 for the treatment of breast cancerMothaffar F Rimawi, Rachel Schiff, C Kent Osborne
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate responseRachel Schiff, Suleiman Massarweh, Jiang Shou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancerC Kent Osborne, Jiang Shou, Suleiman Massarweh, et al.
Pageof 27